ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best drug stocks to buy according to analysts. ANI Pharmaceuticals, Inc ...

ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. ANI Pharmaceuticals (ANIP) is a stock that can certainly grab ...

ANI Pharmaceuticals ANIP has been steadier than its broader sector this year, but it has not fully kept pace with its closest peer set. Shares are up 2.5% year to date, versus a 3.5% gain for the ...

The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will ...

ANI Pharmaceuticals’ ANIP rare disease franchise spearheaded its growth in 2025. This robust growth was fueled by the strong performance of its ACTH-based injection Cortrophin Gel. Cortrophin Gel ...

ANI Pharmaceuticals’ ANIP rare disease franchise has emerged as a major growth catalyst in 2025, with segment revenues more than doubling year over year to $291 million in the first nine months. The ...